Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mark S. Diamond"'
Autor:
Il-Kyu Kim, Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Benjamin M. Kahn, Qinglan Li, Jeffrey H. Lin, Jinyang Li, Robert J. Norgard, Stacy K. Thomas, Maria Merolle, Takeshi Katsuda, John W. Tobias, Timour Baslan, Katerina Politi, Robert H. Vonderheide, Ben Z. Stanger
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Acquired resistance to immunotherapy remains a critical yet incompletely understood biological mechanism. Here, using a mouse model of pancreatic ductal adenocarcinoma (PDAC) to study tumor relapse following immunotherapy-induced responses,
Externí odkaz:
https://doaj.org/article/96e408eb89f447649478a14b903b0f6a
Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bd61703be6f8f63fd62e3622aa9a9e
https://doi.org/10.1158/2326-6066.22544406
https://doi.org/10.1158/2326-6066.22544406
Supplementary Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2578badb8caf9a0908b7d71572ee11ec
https://doi.org/10.1158/2326-6066.22544403
https://doi.org/10.1158/2326-6066.22544403
Supplementary Figure 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285529fe9582d2c8caecab5dca2472b5
https://doi.org/10.1158/2326-6066.22544388.v1
https://doi.org/10.1158/2326-6066.22544388.v1
T-cell recognition of tumor neoantigens is critical for cancer immune surveillance and the efficacy of immunotherapy. Tumors can evade host immunity by altering their antigenicity or orchestrating an immunosuppressive microenvironment, leading to out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1b2b2cfb1c8552148c458eeb6ebc55
https://doi.org/10.1158/2326-6066.c.6550629.v1
https://doi.org/10.1158/2326-6066.c.6550629.v1
Supplementary Figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633d51ff36e4b4ac951d0fd6f60c8bfb
https://doi.org/10.1158/2326-6066.22544397
https://doi.org/10.1158/2326-6066.22544397
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78154233cca2064237e80bc2e3a94f7
https://doi.org/10.1158/2326-6066.22544415.v1
https://doi.org/10.1158/2326-6066.22544415.v1
Supplementary Figure 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d2a4afcf71ab17846061be7afa57ee
https://doi.org/10.1158/2326-6066.22544394.v1
https://doi.org/10.1158/2326-6066.22544394.v1
Supplementary Figure 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c161cfac865c9b5dda2f975c88632a4
https://doi.org/10.1158/2326-6066.22544400
https://doi.org/10.1158/2326-6066.22544400
Publikováno v:
Cancer Immunol Res
T-cell recognition of tumor neoantigens is critical for cancer immune surveillance and the efficacy of immunotherapy. Tumors can evade host immunity by altering their antigenicity or orchestrating an immunosuppressive microenvironment, leading to out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6aa5f42ee1d3540de70d87be651be7
https://doi.org/10.1158/2326-6066.cir-20-0785
https://doi.org/10.1158/2326-6066.cir-20-0785